Cargando…
Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
Although several pharmacological agents are under investigation to be repurposed as therapeutic against COVID-19, not much success has been achieved yet. So, the search for an effective and active option for the treatment of COVID-19 is still a big challenge. The Spike protein (S), RNA-dependent RNA...
Autores principales: | Sharma, Tanuj, Abohashrh, Mohammed, Baig, Mohammad Hassan, Dong, Jae-June, Alam, Mohammad Mahtab, Ahmad, Irfan, Irfan, Safia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901282/ https://www.ncbi.nlm.nih.gov/pubmed/33649700 http://dx.doi.org/10.1016/j.sjbs.2021.02.059 |
Ejemplares similares
-
Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study
por: Baig, Mohammad Hassan, et al.
Publicado: (2021) -
Assessment of IL-12, mRNA expression, vitamin-D level, and their correlation among the Mycobacterium tuberculosis cases
por: Abohashrh, Mohammed, et al.
Publicado: (2022) -
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
por: Kandeel, Mahmoud, et al.
Publicado: (2020) -
The Impact of Body Resistance Training Exercise on Biomedical Profile at High Altitude: A Randomized Controlled Trial
por: Zaman, Gaffar Sarwar, et al.
Publicado: (2021) -
Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19
por: Sharma, Tanuj, et al.
Publicado: (2022)